Response by Zhao Et Al to Letter Regarding Article, “lack of Cardiac Improvement after Cardiosphere-Derived Cell Transplantation in Aging Mouse Hearts”
Zhen-Ao Zhao,Wei Lei,Shumei Miao,Jie Wu,Zeyu Yang,Xinglong Han,Jingjing Li,Meng-Chao Yao,Xing-Ai Lu,Lingjuan He,Yihuan Chen,Bin Zhou,Shijun Hu
DOI: https://doi.org/10.1161/circresaha.118.314175
IF: 23.213
2018-01-01
Circulation Research
Abstract:HomeCirculation ResearchVol. 123, No. 12Response by Zhao et al to Letter Regarding Article, “Lack of Cardiac Improvement After Cardiosphere-Derived Cell Transplantation in Aging Mouse Hearts” Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBResponse by Zhao et al to Letter Regarding Article, “Lack of Cardiac Improvement After Cardiosphere-Derived Cell Transplantation in Aging Mouse Hearts” Zhen-Ao Zhao, Wei Lei, Shumei Miao, Jie Wu, Zhuangzhuang Yang, Xinglong Han and Jingjing Li Mengchao Yao Xing-Ai Lu Lingjuan He Yihuan Chen Bin Zhou Shijun Hu Zhen-Ao ZhaoZhen-Ao Zhao Department of Cardiovascular Surgery of the First Affiliated Hospital, Institute for Cardiovascular Science, Medical College, Soochow University, Suzhou, China *Z.-A. Zhao and W. Lei are joint first authors. Search for more papers by this author , Wei LeiWei Lei Department of Cardiovascular Surgery of the First Affiliated Hospital, Institute for Cardiovascular Science, Medical College, Soochow University, Suzhou, China *Z.-A. Zhao and W. Lei are joint first authors. Search for more papers by this author , Shumei MiaoShumei Miao Department of Cardiovascular Surgery of the First Affiliated Hospital, Institute for Cardiovascular Science, Medical College, Soochow University, Suzhou, China Search for more papers by this author , Jie WuJie Wu Department of Cardiovascular Surgery of the First Affiliated Hospital, Institute for Cardiovascular Science, Medical College, Soochow University, Suzhou, China Search for more papers by this author , Zhuangzhuang YangZhuangzhuang Yang Department of Cardiovascular Surgery of the First Affiliated Hospital, Institute for Cardiovascular Science, Medical College, Soochow University, Suzhou, China Search for more papers by this author , Xinglong HanXinglong Han Department of Cardiovascular Surgery of the First Affiliated Hospital, Institute for Cardiovascular Science, Medical College, Soochow University, Suzhou, China Search for more papers by this author and Jingjing LiJingjing Li Department of Cardiovascular Surgery of the First Affiliated Hospital, Institute for Cardiovascular Science, Medical College, Soochow University, Suzhou, China Search for more papers by this author Mengchao YaoMengchao Yao School of Life Science, Shanghai University, Shanghai, China Search for more papers by this author Xing-Ai LuXing-Ai Lu Department of Cardiovascular Surgery of the First Affiliated Hospital, Institute for Cardiovascular Science, Medical College, Soochow University, Suzhou, China Search for more papers by this author Lingjuan HeLingjuan He State Key Laboratory of Cell Biology, CAS Center for Excellence on Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China Search for more papers by this author Yihuan ChenYihuan Chen Department of Cardiovascular Surgery of the First Affiliated Hospital, Institute for Cardiovascular Science, Medical College, Soochow University, Suzhou, China Search for more papers by this author Bin ZhouBin Zhou The State Key Laboratory of Cell Biology, CAS Center for Excellence on Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China Search for more papers by this author Shijun HuShijun Hu Department of Cardiovascular Surgery of the First Affiliated Hospital, Institute for Cardiovascular Science, Medical College, Soochow University, Suzhou, China Search for more papers by this author Originally published6 Dec 2018https://doi.org/10.1161/CIRCRESAHA.118.314175Circulation Research. 2018;123:e67–e68In Response:We disagree with the claims made by the letter from Ibrahim et al on our recent study on lack of cardiac improvement after cardiosphere-derived cell (CDC) transplantation in aging mice.1 It should be clear that our study is to investigate mouse aging using strain-matched CDCs. Therefore, we mainly followed the protocol by Messina et al,2 which defined mouse CDCs. In previous mouse CDC reports by the letter writers,3,4 they only collected loosely adherent cells for cardiosphere formation. Although not described clearly, most of their loosely adherent cells should be phase-bright cells, which were loosely adherent. Moreover, in human CDC reports, they used a different and rougher way to harvest all cells surrounding the explants,5,6 which could lead to unexpected heterogeneity and instability of CDC culture. Evidence from their laboratory showed greatly varied percentages of CD90+ cells (0.2%–94.6%) in CDCs.6 Furthermore, the methods they cited in the letter were all from their own lab, whereas our method had been adopted widely.2,7–9 It remains unconvincing to assert that their protocol is widely accepted and superior to multiple other independent groups.To obtain more CDCs, we used about 7 days for cardiosphere formation. However, we did not observe any apoptotic cores (Figure 1E in the study by Zhao et al1). Additionally, the sizes of our cardiospheres were similar to previous report.2 In the letter writers’ studies, they used 12 days for human cardiosphere growth, when growth was robust, and the sizes of cardiospheres were >200 μm (Figure 1F in the study by Smith et al).5 No standard 72-hour period was mentioned in the studies they cited in the letter. Additionally, Messina et al2 found some mouse cardiospheres beat spontaneously, whereas human cardiospheres did not beat. We also observed that few mouse cardiospheres beat.In our study, we characterized CDC markers based on the mouse CDC study by Messina et al2. In general, even in the letter writers’ mouse studies,3,4 CD105 and CD45 were not routinely detected in mouse CDCs.2,7,10 In their human CDC reports, immunostaining showed CD105 was only expressed in nonproliferative cells (Ki67 negative) on the periphery of cardiospheres,3,5 whereas flow cytometry showed that almost all CDCs expressed CD105.5,11 These contradictory results fail to support CD105 as a reliable CDC marker.CDCs are known as a mixture of heterogeneous cell populations.2,3 Although Sca-1+ cells were >50% in CDCs derived from atria,7 the proportion was 4% to 30% in CDCs derived from whole heart.2,10 In our study, the proportion of Sca-1+ cells exactly fell within the published Sca-1 ratio scope, and the proportion of CD34+ cells was also consistent with a previous study.2 By contrast, the letter writers used CD34 as a positive marker in one human CDC study5 and as a negative marker in another one,11 exposing the heterogeneity and instability of CDC markers used in their laboratory.Our mouse study clearly included young controls to validate cardiac dysfunction in the Online Data Supplement and to quantify the fibrosis markers (Figure 4B in the study by Zhao et al1). Likewise, the fibrosis in PBS-injected rat heart was also focal (Figure 2E in the study by Grigorian-Shamagian et al),12 which we speculate was induced by needle injury as discussed in our study. For telomere shortening, our results were supported by a Nature article showing reduced telomere length in C57BL/6 aging heart.13 By contrast, the letter writers’ study failed to include young controls for telomere study (Figure 4 in the study by Grigorian-Shamagian et al).12 Most importantly, the decrease of E/A is a key feature of aging heart, consistently reported in human, mouse, and rat studies.14,15 Contradicting prior studies, their data controversially showed that E/A was increased in aging rat (Online Figure I in the study by Grigorian-Shamagian et al).12 Lastly, they applied 2 different cell transplantation strategies and mixed the data for statistical analysis for unknown reasons.12 The error-prone experimental design combined with controversial data in the letter writers’ studies make their arguments unconvincing.12 Only additional replicable studies with adequate safeguards preferably conducted by diverse and nonpartisan groups without conflicts of interests can resolve the controversy.Zhen-Ao Zhao*Wei Lei*Shumei MiaoJie WuZhuangzhuang YangXinglong HanJingjing LiDepartment of Cardiovascular Surgery of the First Affiliated HospitalInstitute for Cardiovascular ScienceMedical CollegeSoochow UniversitySuzhou, ChinaMengchao YaoSchool of Life ScienceShanghai UniversityShanghai, ChinaXing-Ai LuDepartment of Cardiovascular Surgery of the First Affiliated HospitalInstitute for Cardiovascular ScienceMedical CollegeSoochow UniversitySuzhou, ChinaLingjuan HeState Key Laboratory of Cell BiologyCAS Center for Excellence on Molecular Cell ScienceShanghai Institute of Biochemistry and Cell BiologyChinese Academy of SciencesUniversity of Chinese Academy of SciencesShanghai, ChinaYihuan ChenDepartment of Cardiovascular Surgery of the First Affiliated HospitalInstitute for Cardiovascular ScienceMedical CollegeSoochow UniversitySuzhou, ChinaBin ZhouThe State Key Laboratory of Cell BiologyCAS Center for Excellence on Molecular Cell ScienceShanghai Institute of Biochemistry and Cell BiologyChinese Academy of SciencesUniversity of Chinese Academy of SciencesShanghai, ChinaShijun HuDepartment of Cardiovascular Surgery of the First Affiliated HospitalInstitute for Cardiovascular ScienceMedical CollegeSoochow UniversitySuzhou, ChinaSources of FundingThis study was supported by National Key R&D Program of China (2017YFA0103700), National Natural Science Foundation of China (91739106, 81500277, 81770257, and 81600218), Natural Science Foundation of Jiangsu Province (BK20150320, BK20170002, BK20150321, and BK20150345), Suzhou Municipal Science and Technology Foundation (SYS201675 and SYS201540), Natural Science Foundation for Colleges and Universities in Jiangsu Province (17KJA310006 and 15KJB180017), National Clinical Key Specialty of Cardiovascular Surgery, Jiangsu Clinical Research Center for Cardiovascular Surgery, Jiangsu Province Key Discipline/Laboratory of Medicine (XK201118), and National Center for International Research (2017B01012).DisclosuresNone.FootnotesLetters to the Editor will be published, if suitable, as space permits. They should not exceed 1000 words (typed double-spaced) in length and may be subject to editing or abridgment.*Z.-A. Zhao and W. Lei are joint first authors.References1. Zhao ZA, Han X, Lei W, Li J, Yang Z, Wu J, Yao M, Lu XA, He L, Chen Y, Zhou B, Hu S. Lack of cardiac improvement after cardiosphere-derived cell transplantation in aging mouse hearts.Circ Res. 2018; 123:e21–e31. doi: 10.1161/CIRCRESAHA.118.313005LinkGoogle Scholar2. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, Salio M, Battaglia M, Latronico MV, Coletta M, Vivarelli E, Frati L, Cossu G, Giacomello A. Isolation and expansion of adult cardiac stem cells from human and murine heart.Circ Res. 2004; 95:911–921. doi: 10.1161/01.RES.0000147315.71699.51LinkGoogle Scholar3. Davis DR, Zhang Y, Smith RR, Cheng K, Terrovitis J, Malliaras K, Li TS, White A, Makkar R, Marbán E. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue.PLoS One. 2009; 4:e7195. doi: 10.1371/journal.pone.0007195CrossrefMedlineGoogle Scholar4. Malliaras K, Zhang Y, Seinfeld J, Galang G, Tseliou E, Cheng K, Sun B, Aminzadeh M, Marbán E. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart.EMBO Mol Med. 2013; 5:191–209. doi: 10.1002/emmm.201201737CrossrefMedlineGoogle Scholar5. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E, Giacomello A, Abraham MR, Marbán E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.Circulation. 2007; 115:896–908. doi: 10.1161/CIRCULATIONAHA.106.655209LinkGoogle Scholar6. Cheng K, Ibrahim A, Hensley MT, Shen D, Sun B, Middleton R, Liu W, Smith RR, Marbán E. Relative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarction.J Am Heart Assoc. 2014; 3:e001260. doi: 10.1161/JAHA.114.001260LinkGoogle Scholar7. Hsiao LC, Perbellini F, Gomes RS, Tan JJ, Vieira S, Faggian G, Clarke K, Carr CA. Murine cardiosphere-derived cells are impaired by age but not by cardiac dystrophic dysfunction.Stem Cells Dev. 2014; 23:1027–1036. doi: 10.1089/scd.2013.0388CrossrefMedlineGoogle Scholar8. Kasai-Brunswick TH, Costa AR, Barbosa RA, Farjun B, Mesquita FC, Silva Dos Santos D, Ramos IP, Suhett G, Brasil GV, Cunha ST, Brito JO, Passipieri JD, Carvalho AB, Campos de Carvalho AC. Cardiosphere-derived cells do not improve cardiac function in rats with cardiac failure.Stem Cell Res Ther. 2017; 8:36. doi: 10.1186/s13287-017-0481-xCrossrefMedlineGoogle Scholar9. Walravens AS, Vanhaverbeke M, Ottaviani L, Gillijns H, Trenson S, Driessche NV, Luttun A, Meyns B, Herijgers P, Rega F, Heying R, Sampaolesi M, Janssens S. Molecular signature of progenitor cells isolated from young and adult human hearts.Sci Rep. 2018; 8:9266. doi: 10.1038/s41598-018-26969-2CrossrefMedlineGoogle Scholar10. Ye J, Boyle A, Shih H, Sievers RE, Zhang Y, Prasad M, Su H, Zhou Y, Grossman W, Bernstein HS, Yeghiazarians Y. Sca-1+ cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injury.PLoS One. 2012; 7:e30329. doi: 10.1371/journal.pone.0030329CrossrefMedlineGoogle Scholar11. Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, Matsushita N, Blusztajn A, Terrovitis J, Kusuoka H, Marbán L, Marbán E. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells.J Am Coll Cardiol. 2012; 59:942–953. doi: 10.1016/j.jacc.2011.11.029CrossrefMedlineGoogle Scholar12. Grigorian-Shamagian L, Liu W, Fereydooni S, Middleton RC, Valle J, Cho JH, Marbán E. Cardiac and systemic rejuvenation after cardiosphere-derived cell therapy in senescent rats.Eur Heart J. 2017; 38:2957–2967. doi: 10.1093/eurheartj/ehx454CrossrefMedlineGoogle Scholar13. Boon RA, Iekushi K, Lechner S, et al. MicroRNA-34a regulates cardiac ageing and function.Nature. 2013; 495:107–110. doi: 10.1038/nature11919CrossrefMedlineGoogle Scholar14. Dai DF, Rabinovitch PS. Cardiac aging in mice and humans: the role of mitochondrial oxidative stress.Trends Cardiovasc Med. 2009; 19:213–220. doi: 10.1016/j.tcm.2009.12.004CrossrefMedlineGoogle Scholar15. Groban L, Pailes NA, Bennett CD, Carter CS, Chappell MC, Kitzman DW, Sonntag WE. Growth hormone replacement attenuates diastolic dysfunction and cardiac angiotensin II expression in senescent rats.J Gerontol A Biol Sci Med Sci. 2006; 61:28–35.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Dong M, Yang Z, Fang H, Xiang J, Xu C, Zhou Y, Wu Q and Liu J (2020) Aging Attenuates Cardiac Contractility and Affects Therapeutic Consequences for Myocardial Infarction, Aging and disease, 10.14336/AD.2019.0522, 11:2, (365), . December 7, 2018Vol 123, Issue 12 Advertisement Article InformationMetrics © 2018 American Heart Association, Inc.https://doi.org/10.1161/CIRCRESAHA.118.314175PMID: 30566052 Originally publishedDecember 6, 2018 PDF download Advertisement